Английская Википедия:ABT-436

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Drugbox

ABT-436 is an orally active, highly selective vasopressin V1B receptor antagonist which was under development by Abbott Laboratories and AbbVie for the treatment of major depressive disorder, anxiety disorders, and alcoholism but was discontinued.[1][2][3] It reached phase II clinical trials prior to the discontinuation of its development.[1][3]

See also

References

Шаблон:Reflist

Шаблон:Oxytocin and vasopressin receptor modulators

Шаблон:Systemic-hormonal-drug-stub